Home Healthcare Pharmaceuticals Antibiotic Resistant Infections Treatment Market

Antibiotic Resistant Infections Treatment Market Size, Share & Trends Analysis Report By Drug Class (Beta Lactam Combinations, Cephalosporins, Carbapenems and Penems, Tetracyclines, Glycopeptides, Oxazolidinones, Fluoroquinolones, Aminoglycosides, Polymyxins, Others), By Infection Type (Urinary Tract Infections, Pneumonia, Skin and Soft Tissue Infections, Intra Abdominal Infections, Bloodstream Infections, Others), By Pathogen (Staphylococcus aureus, Enterococcus Species, Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii, Streptococcus pneumoniae, Others), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 26, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Antibiotic Resistant Infections Treatment Market, By Drug Class 2025-2034 (USD MILLION/ Units)
    1. Beta Lactam Combinations
    2. Cephalosporins
    3. Carbapenems and Penems
    4. Tetracyclines
    5. Glycopeptides
    6. Oxazolidinones
    7. Fluoroquinolones
    8. Aminoglycosides
    9. Polymyxins
    10. Others  
  2. Antibiotic Resistant Infections Treatment Market, By Infection Type 2025-2034 (USD MILLION/ Units)
    1. Urinary Tract Infections
    2. Pneumonia
    3. Skin and Soft Tissue Infections
    4. Intra Abdominal Infections
    5. Bloodstream Infections
    6. Others  
  3. Antibiotic Resistant Infections Treatment Market, By Pathogen 2025-2034 (USD MILLION/ Units)
    1. Staphylococcus aureus
    2. Enterococcus Species
    3. Enterobacterales
    4. Pseudomonas aeruginosa
    5. Acinetobacter baumannii
    6. Streptococcus pneumoniae
    7. Others  
  4. Antibiotic Resistant Infections Treatment Market, By Route of Administration 2025-2034 (USD MILLION/ Units)
    1. Oral
    2. Parenteral  
  5. Antibiotic Resistant Infections Treatment Market, By Distribution Channel 2025-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
  6. Regional Antibiotic Resistant Infections Treatment Market
    1. North America
      1. North America Antibiotic Resistant Infections Treatment Market By Drug Class 2025-2034 (USD MILLION/ Units)
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
      2. North America Antibiotic Resistant Infections Treatment Market By Infection Type 2025-2034 (USD MILLION/ Units)
        1. Urinary Tract Infections
        2. Pneumonia
        3. Skin and Soft Tissue Infections
        4. Intra Abdominal Infections
        5. Bloodstream Infections
        6. Others  
      3. North America Antibiotic Resistant Infections Treatment Market By Pathogen 2025-2034 (USD MILLION/ Units)
        1. Staphylococcus aureus
        2. Enterococcus Species
        3. Enterobacterales
        4. Pseudomonas aeruginosa
        5. Acinetobacter baumannii
        6. Streptococcus pneumoniae
        7. Others  
      4. North America Antibiotic Resistant Infections Treatment Market By Route of Administration 2025-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral  
      5. North America Antibiotic Resistant Infections Treatment Market By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      6. U.S.
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      7. Canada
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
    2. Europe
      1. Europe Antibiotic Resistant Infections Treatment Market By Drug Class 2025-2034 (USD MILLION/ Units)
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
      2. Europe Antibiotic Resistant Infections Treatment Market By Infection Type 2025-2034 (USD MILLION/ Units)
        1. Urinary Tract Infections
        2. Pneumonia
        3. Skin and Soft Tissue Infections
        4. Intra Abdominal Infections
        5. Bloodstream Infections
        6. Others  
      3. Europe Antibiotic Resistant Infections Treatment Market By Pathogen 2025-2034 (USD MILLION/ Units)
        1. Staphylococcus aureus
        2. Enterococcus Species
        3. Enterobacterales
        4. Pseudomonas aeruginosa
        5. Acinetobacter baumannii
        6. Streptococcus pneumoniae
        7. Others  
      4. Europe Antibiotic Resistant Infections Treatment Market By Route of Administration 2025-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral  
      5. Europe Antibiotic Resistant Infections Treatment Market By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      6. U.K.
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      7. Germany
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      8. France
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      9. Spain
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      10. Italy
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      11. Russia
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      12. Nordic
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      13. Benelux
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      14. Rest of Europe
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
    3. APAC
      1. APAC Antibiotic Resistant Infections Treatment Market By Drug Class 2025-2034 (USD MILLION/ Units)
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
      2. APAC Antibiotic Resistant Infections Treatment Market By Infection Type 2025-2034 (USD MILLION/ Units)
        1. Urinary Tract Infections
        2. Pneumonia
        3. Skin and Soft Tissue Infections
        4. Intra Abdominal Infections
        5. Bloodstream Infections
        6. Others  
      3. APAC Antibiotic Resistant Infections Treatment Market By Pathogen 2025-2034 (USD MILLION/ Units)
        1. Staphylococcus aureus
        2. Enterococcus Species
        3. Enterobacterales
        4. Pseudomonas aeruginosa
        5. Acinetobacter baumannii
        6. Streptococcus pneumoniae
        7. Others  
      4. APAC Antibiotic Resistant Infections Treatment Market By Route of Administration 2025-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral  
      5. APAC Antibiotic Resistant Infections Treatment Market By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      6. China
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      7. Korea
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      8. Japan
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      9. India
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      10. Australia
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      11. Taiwan
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      12. South East Asia
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      13. Rest of Asia-Pacific
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Antibiotic Resistant Infections Treatment Market By Drug Class 2025-2034 (USD MILLION/ Units)
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
      2. Middle East and Africa Antibiotic Resistant Infections Treatment Market By Infection Type 2025-2034 (USD MILLION/ Units)
        1. Urinary Tract Infections
        2. Pneumonia
        3. Skin and Soft Tissue Infections
        4. Intra Abdominal Infections
        5. Bloodstream Infections
        6. Others  
      3. Middle East and Africa Antibiotic Resistant Infections Treatment Market By Pathogen 2025-2034 (USD MILLION/ Units)
        1. Staphylococcus aureus
        2. Enterococcus Species
        3. Enterobacterales
        4. Pseudomonas aeruginosa
        5. Acinetobacter baumannii
        6. Streptococcus pneumoniae
        7. Others  
      4. Middle East and Africa Antibiotic Resistant Infections Treatment Market By Route of Administration 2025-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral  
      5. Middle East and Africa Antibiotic Resistant Infections Treatment Market By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      6. UAE
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      7. Turkey
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      8. Saudi Arabia
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      9. South Africa
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      10. Egypt
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      11. Nigeria
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      12. Rest of MEA
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
    5. LATAM
      1. LATAM Antibiotic Resistant Infections Treatment Market By Drug Class 2025-2034 (USD MILLION/ Units)
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
      2. LATAM Antibiotic Resistant Infections Treatment Market By Infection Type 2025-2034 (USD MILLION/ Units)
        1. Urinary Tract Infections
        2. Pneumonia
        3. Skin and Soft Tissue Infections
        4. Intra Abdominal Infections
        5. Bloodstream Infections
        6. Others  
      3. LATAM Antibiotic Resistant Infections Treatment Market By Pathogen 2025-2034 (USD MILLION/ Units)
        1. Staphylococcus aureus
        2. Enterococcus Species
        3. Enterobacterales
        4. Pseudomonas aeruginosa
        5. Acinetobacter baumannii
        6. Streptococcus pneumoniae
        7. Others  
      4. LATAM Antibiotic Resistant Infections Treatment Market By Route of Administration 2025-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral  
      5. LATAM Antibiotic Resistant Infections Treatment Market By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      6. Brazil
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      7. Mexico
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      8. Argentina
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      9. Chile
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      10. Colombia
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
      11. Rest of LATAM
        1. Beta Lactam Combinations
        2. Cephalosporins
        3. Carbapenems and Penems
        4. Tetracyclines
        5. Glycopeptides
        6. Oxazolidinones
        7. Fluoroquinolones
        8. Aminoglycosides
        9. Polymyxins
        10. Others  
        11. Urinary Tract Infections
        12. Pneumonia
        13. Skin and Soft Tissue Infections
        14. Intra Abdominal Infections
        15. Bloodstream Infections
        16. Others  
        17. Staphylococcus aureus
        18. Enterococcus Species
        19. Enterobacterales
        20. Pseudomonas aeruginosa
        21. Acinetobacter baumannii
        22. Streptococcus pneumoniae
        23. Others  
        24. Oral
        25. Parenteral  
        26. Hospital Pharmacies
        27. Retail Pharmacies
        28. Online Pharmacies
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.